Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Microbiome Composition and Biomarkers in Pharmaco Resistant and Pharmaco-Sensitive Epilepsy

NCT04308252 is registered in ClinicalTrials.gov with Senda Biosciences as lead sponsor.

NCT NCT04308252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04308252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Microbiome Composition and Biomarkers in Pharmaco Resistant and Pharmaco-Sensitive Epilepsy
Lead sponsor
Senda Biosciences
Phase
Observational
Overall status
Withdrawn
Start date
March 15, 2020
Completion date
March 15, 2022
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy in children, pharmaco-resistant epilepsy